Literature DB >> 6884504

Multi-site phosphorylation in ox-kidney branched-chain 2-oxoacid dehydrogenase complex.

K S Lau, C E Phillips, P J Randle.   

Abstract

Tryptic [32P]phosphopeptides were prepared from [32P]phosphorylated ox-kidney branched-chain complex and analysed by high-voltage paper electrophoresis at pH 1.9. In the maximally phosphorylated complex 3 tryptic [32P]phosphopeptides were identified (TA, TB, TC). RF-values relative to N6-dinitrophenyllysine were (mean +/- SEM for 25 obs.): TA, 1.53 +/- 0.03; TB, 1.07 +/- 0.02; TC, 0.65 +/- 0.01. Relative rates of phosphorylation were TA greater than TB greater than TC. Phosphorylation of TA reached a maximum when about 66% of the complex was inactivated. Phosphorylation of TB and TC was associated mainly with 66-95% inactivation of the complex.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6884504     DOI: 10.1016/0014-5793(83)80955-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  The dihydrolipoyl acyltransferase (BCE2) subunit of the plant branched-chain alpha-ketoacid dehydrogenase complex forms a 24-mer core with octagonal symmetry.

Authors:  B P Mooney; M T Henzl; J A Miernyk; D D Randall
Journal:  Protein Sci       Date:  2000-07       Impact factor: 6.725

2.  Maple syrup urine disease. Complete primary structure of the E1 beta subunit of human branched chain alpha-ketoacid dehydrogenase complex deduced from the nucleotide sequence and a gene analysis of patients with this disease.

Authors:  Y Nobukuni; H Mitsubuchi; F Endo; I Akaboshi; J Asaka; I Matsuda
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

3.  Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.

Authors:  Samantha J Clarke; Igor Khaliulin; Manika Das; Joanne E Parker; Kate J Heesom; Andrew P Halestrap
Journal:  Circ Res       Date:  2008-03-20       Impact factor: 17.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.